SEC 13F Intelligence

Navellier & Associates Inc / WST

Navellier & Associates Inc’s West Pharmaceutical Svsc Inc Position

Does Navellier & Associates Inc own West Pharmaceutical Svsc Inc (WST)? Not currently — the last reported position was 41.2K shares worth $17M in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$17M
Q1 2022
Shares
41.2K
% of Portfolio
+2.88%
Quarters Held
7
position exited

Position History WST

Reported value by quarter
Q3 ’20: $4MQ3 ’20Q4 ’20: $5MQ4 ’20Q1 ’21: $6MQ1 ’21Q2 ’21: $8MQ2 ’21Q3 ’21: $18MQ3 ’21Q4 ’21: $20MQ4 ’21Q1 ’22: $17MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202241.2K$17M+2.88%
Q4 202142.9K$20M+2.93%
Q3 202142.7K$18M+2.73%
Q2 202122.7K$8M+1.23%
Q1 202120.9K$6M+1.06%
Q4 202018.3K$5M+0.94%
Q3 202016.2K$4M+0.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Navellier & Associates Inc’s full portfolio or all institutional holders of WST.